Last reviewed · How we verify
Binge Eating Disorder
Approved treatments
- Vyvanse · Takeda
Vyvanse works by blocking the dopamine transporter, allowing more dopamine to be available in the brain. - Vyvanse · Vanderbilt University
Pipeline
- DEXTROAMPHETAMINE — Phase 3
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Binge Eating Disorder patent landscape — cliff calendar, originator estates, attackable patents
- Binge Eating Disorder treatment landscape brief
- Binge Eating Disorder treatment updates RSS
Frequently asked questions about Binge Eating Disorder
What drugs treat Binge Eating Disorder?
Tracked treatments include Vyvanse.
What is the treatment for Binge Eating Disorder?
Standard treatment for Binge Eating Disorder includes Vyvanse. See the treatment landscape page for first-line, second-line and salvage options.
What new drugs are in development for Binge Eating Disorder?
1 pipeline drugs tracked. Top candidates: DEXTROAMPHETAMINE.
Related
- Treatment landscape: Binge Eating Disorder patent cliff · Binge Eating Disorder CI report
- Treatment: Vyvanse · Takeda
- Treatment: Vyvanse · Vanderbilt University
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing